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Abstract Alzheimer’s disease (AD) is a complex,
multicausal disorder involving several spatiotempo-
ral scales and scientific domains. While many studies
focus on specific parts of this system, the complexity
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of AD is rarely studied as a whole. In this work, we
apply systems thinking to map out known causal mec-
hanisms and risk factors ranging from intracellular
to psychosocial scales in sporadic AD. We report on
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the first systemic causal loop diagram (CLD) for AD,
which is the result of an interdisciplinary group model
building (GMB) process. The GMB was based on
the input of experts from multiple domains and all
proposed mechanisms were supported by scientific lit-
erature. The CLD elucidates interaction and feedback
mechanisms that contribute to cognitive decline from
midlife onward as described by the experts. As an
immediate outcome, we observed several non-trivial
reinforcing feedback loops involving factors at multi-
ple spatial scales, which are rarely considered within
the same theoretical framework. We also observed
high centrality for modifiable risk factors such as
social relationships and physical activity, which sug-
gests they may be promising leverage points for inter-
ventions. This illustrates how a CLD from an interdis-
ciplinary GMB process may lead to novel insights into
complex disorders. Furthermore, the CLD is the first
step in the development of a computational model for
simulating the effects of risk factors on AD.
Keywords Systems thinking · Alzheimer’s disease ·
Causal loop diagram · Multicausal · Complexity ·
Group model building · Centrality
Introduction
Alzheimer’s disease is multicausal
Alzheimer’s disease (AD) is a complex disorder with a
multicausal etiology that remains difficult to elucidate
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despite the many and diverse research efforts, which
focus on various causal mechanisms. For instance,
the most prominent causal hypothesis concerns the
aggregation of amyloid-beta protein in the brain, lead-
ing to the formation of senile plaques and neuronal
dysfunction (Hardy and Selkoe 2002; Karran et al.
2011). However, the relationship between this amy-
loid cascade and the onset and progression of AD
lacks specificity (Mortimer 2012) and weakens with
increasing age and frailty (Savva GM et al. 2009; Wal-
lace et al. 2019). Furthermore, clinical trials based on
this hypothesis have not yet yielded effective disease-
modifying treatments (Cummings et al. 2019; Karran
et al. 2011). One may thus tentatively conclude that
while the amyloid cascade appears to play a role in
AD, it is far from the complete story (Pimplikar 2009).
Indeed, in recent years, researchers argue that
unraveling this complexity at the systemic level
may be crucial for the development of effica-
cious treatments (Pomorska and Ockene 2017; Tang
et al. 2019; Rollo et al. 2016). This is supported
by many additional mechanisms that are probably
involved in the etiology of AD, such as glucose
metabolism and oxidative stress (Butterfield and Hal-
liwell 2019; Nunomura et al. 2006), vascular dys-
function (Sweeney et al. 2019), and inflammation
(Newcombe et al. 2018; Heneka et al. 2015). This
multicausality is increasingly recognized (Fotuhi et al.
2009; Sweeney et al. 2019), but a comprehensive
understanding of the interactions between these causes
is lacking. Such an overarching understanding of
AD requires intense interdisciplinary collaboration
between various traditional scientific disciplines that
now largely focus on a single scale or mechanism
(Kuljis 2009; van Dijk et al. 2015), supported by
methodologies that are largely novel in this field,
originating from complexity science and the study of
complex adaptive systems (Braithwaite et al. 2018).
Applying systems thinking to Alzheimer’s disease
Systems thinking offers a methodology to realize
such a holistic, interdisciplinary approach. In this
way, it helps to understand the behavior of complex
adaptive systems such as organs and organisms, and
may thus also be useful in disentangling the interac-
tion and feedback mechanisms that lead to cognitive
decline. It offers validated methods for identifying
causal mechanisms and the interactions between them.
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Unsurprisingly, systems thinking is being increasingly
recognized and utilized in biomedical and neuro-
science literature (Wittenborn et al. 2016; Kenzie et al.
2018; Vandenbroeck et al. 2007).
An important concept in systems thinking is the
causal loop diagram (CLD), which is a conceptual
model of relevant mechanisms and their interactions.
In this paper, we report on the first systemic CLD for
AD, which was realized using group model building
(GMB). The CLD comprises the combined concep-
tual model of an extensive interdisciplinary group of
AD researchers and computational modelers, checked
against the scientific literature. We do not present the
CLD as a complete representation of reality but rather
as a summary of knowledge, agreed upon by this spe-
cific group of experts, which helps elucidate central
processes involved in the onset and progression of AD.
Methods
Causal loop diagram
CLDs visualize the known or assumed causal structure
of a system and consist of variables and connections
drawn as arrows between the variables. These connec-
tions have specific directions, in line with the underly-
ing causal relationships, and typically have positive or
negative polarity (Bala et al. 2017). A positive connec-
tion (+) implies that when the causal variable changes
in one direction, the variable it connects to changes in
the same direction; a negative connection (-) implies
that when the causal variable changes in one direc-
tion, the variable it connects to changes in the opposite
direction. A direct connection between two variables
implies an effect that does not go via any of the other
variables in the CLD.
As the name suggests, an important feature of
CLDs is the presence of feedback loops. Feedback
mechanisms are important drivers of the nonlinear
behavior of dynamical systems (Forrester 2009; Lit-
tlejohns et al. 2018) and can reinforce or balance
the impact of stimuli. Reinforcing loops have a self-
strengthening effect and can push the system out of
balance, whereas balancing loops have a self-limiting
effect and promote equilibrium restoration and thus
support homeostasis. Identifying reinforcing loops
may be particularly important for understanding the
amplification of inter-individual differences in risk
profiles, which can result in substantial heterogeneity
(Sterman 2000) in terms of onset and progression of
AD.
Feedback loops with only two variables are “direct,”
while loops consisting of more than two variables are
defined as “indirect.” When the variables in a loop all
occur in the same characteristic spatial scale (e.g., cel-
lular), the loop is referred to as “within-scale.” When
the variables in the loop occur in different spatial
scales, the loop is referred to as “cross-scale.” Identi-
fying cross-scale loops is of particular interest because
they can be easily overlooked when studying the
system exclusively from one spatial scale or scien-
tific domain. From a systems perspective, all known
and hypothesized causal relationships between vari-
ables should be taken into account, even those that
are separated by spatial or temporal scales (Forrester
1971).
Group model building
Group model building (GMB) is a participatory
method for involving experts in developing concep-
tual or computational models (Vennix 1999; Andersen
et al. 2007; Hovmand et al. 2012). In GMB, the men-
tal models and assumptions of experts are elicited and
captured in a shared model, which is the result of con-
sensus in the group (Be´rard 2010; Vennix 1996). The
resulting model is a summary of explicit, tested, and
integrated knowledge of the group.
We organized two GMB sessions with two weeks in
between, specifically aimed at developing a CLD. We
aimed to include a sufficiently large variety of expertise
while ensuring some overlap. To this end, we formulated
an expertise table (see supplementary materials). The
group consisted of thirteen domain experts from a
wide scope of AD research and two experts in com-
plexity research and computational modeling. The
expressed purpose of our GMB sessions was to
structurally explain the difference between cognitive
decline trajectories in sporadic AD compared with
normal aging, starting from midlife. We defined AD
using clinical criteria (McKhann et al. 2011) and
focused on sporadic AD, meaning that we did not take
into account the genes associated with familial AD:
PSEN1, PSEN2, and APP (Dorszewska et al. 2016).
During the GMB sessions, a facilitator (EAJAR)
guided the group discussions and a computational
modeler (JFU) sketched resulting versions of the CLD
GeroScience
on a screen using Vensim PLE (Version 7.3.5) (Vensim
2019). We alternated between phases of divergence
and convergence. During divergence, the nominal
group technique (Gustafson et al. 1986) was applied,
during which the experts individually wrote down
variables to add to the CLD. These variables were then
collected and displayed on the screen for all partici-
pants to see. During convergence, debate was encour-
aged between experts to reach a consensus about the
addition or deletion of certain variables or connec-
tions. Any proposed additions were discussed in the
group and only added to the CLD when objections
were resolved and a consensus was reached. Dur-
ing the second session, three subgroups were formed
based on the main research topics of the experts (see
the “Results” section). The subgroups were tasked
with checking the parts of the model most closely con-
nected to their area of expertise. The changes made
by these subgroups were presented and discussed with
the rest of the group.
After each GMB session, a summary report con-
taining all results, considerations, and discussion
points was sent to the participating experts. The
experts were then asked to provide feedback on the
reports of both sessions. After the final session, the
experts provided scientific evidence in the form of lit-
erature references for each of the connections in the
CLD together with the modeling team. This resulted
in several additional changes to the CLD, which were
communicated back to and accepted by the group.
Network analysis
The causal connections in the resulting CLD can
be interpreted to form a network structure. For net-
work processes, a typical initial analysis is to identify
structurally important, or “central”, variables. Such an
analysis can also help pinpoint central drivers of dis-
ease in CLDs (McGlashan et al. 2016). To this end, we
calculated the betweenness centrality (BC) and close-
ness centrality (CC) for each of the variables in the
CLD.
In a CLD, shortest paths exist between each pair
of variables, which correspond to sequences of con-
nections that contain the least number of mediating
variables in the causal pathway. If mediating vari-
ables are seen as possible points of interfering with, or
adding noise to, the causal pathway then it follows that
shortest paths tend to be the strongest causal pathways.
As such, measures that are defined in terms of shortest
paths, such as BC and CC (Brandes et al. 2016), could
be informative of the importance of factors in a causal
way. In particular, variables with high BC lie on many
of the shortest paths between other variables, mak-
ing them potentially important connectors (Ahmed
2017). That is, mediating multiple different causal
pathways simultaneously. These variables could be
succinct points for diagnosing aberrant system dynam-
ics and also serve as potential targets for interventions.
Complementarily, variables with high closeness have
shortest paths to many other variables in the CLD with
a short distance, i.e., few mediating variables, render-
ing them potentially efficient spreaders of information
(Ahmed 2017). These variables could thus also be
good starting points for interventions.
The normalized BC of variable v is calculated using
Eq. 1, where N is the number of variables in the CLD,
σ(s, t) is the number of shortest paths between vari-
ables s and t , and σ(s, t |v) is the number of those
shortest paths that pass through variable v.
BCv = 1
(N − 1)(N − 2)
∑
s,t
σ (s, t |v)
σ (s, t)
(1)
The CC of variable v is calculated using Eq. 2,
where n − 1 is the number of reachable variables
and d(v, u) is the distance of the shortest path from
variable v to variable u.
CCv = (n − 1) 1∑n−1
u=1 d(v, u)
(2)
In order to test the robustness of these measures to
possible errors in the structure of the CLD, we cre-
ated 1000 alternative CLDs, each with 5 mutations
in them compared with the original. These mutations
were equiprobable and consisted of either a random
rewiring (e.g., some connection A->B is replaced by
connection A->C) or the random addition or deletion
of a connection. Centrality measures were calculated
for each of these alternative CLDs and the interquar-
tile ranges of the resulting distributions were used to
construct error bars.
Another way of assessing the behavior of the sys-
tem represented by a CLD is to study its feedback
loops, which can result in nonlinear influences of
the variables (Forrester 2009). Important within- and
cross-scale feedback loops are therefore visualized
in the CLD and the potential relevance of several
examples to AD will be discussed.
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Results
The CLD shown in Fig. 1 is a graphical depiction of the
combined multidisciplinary knowledge of fifteen
experts. These experts proposed, discussed, and agreed
on 38 variables and 150 connections between them.
The variables in the CLD were divided into three cate-
gories: brain health, physical health, and psychosocial
health. These categories correspond to the subgroups
in which the experts were divided and can be found in
the supplementary material, together with definitions
of each of the variables as well as supporting evidence
for the connections. An interactive visualization of
the CLD was created in Kumu (2019) which can be
found https://cldforad.kumu.io/mapping-the-complex-
multicausality-in-alzheimers-disease?token=l6CvrnW
TeDcLkHRl.
Variable centrality
The centrality measures for each of the variables
in the CLD are given in Fig. 2. Spearman’s rank-
correlation coefficient between the two measures (BC
and CC) is ρ = 0.50. Neuronal dysfunction has a very
high BC and is clearly an important variable in the
CLD, connecting many pathophysiological variables
to structural brain damage, daily and cognitive func-
tioning. The central position of neuronal dysfunction
(and neuronal loss, which is the ultimate state of neu-
ronal dysfunction) in the CLD may indicate its role
as a final common pathway that is implicated in AD:
at the level of the brain most mechanisms cause cog-
nitive decline via neuronal dysfunction. Furthermore,
at the interface of the circulation and brain, cerebral
endothelial dysfunction appears to have an important
role connecting risk factors such as physical inactiv-
ity, obesity, dyslipidemia, diabetes, and hypertension
to brain pathology. That being said, the experts also
agreed on paths to neuronal dysfunction that do not go
via cerebral endothelial dysfunction, such as effects of
smoking and alcohol use via DNA methylation (Cor-
ley et al. 2019; Xu et al. 2019). Lifestyle factors like
social relationships, physical activity, healthy dietary
patterns, sleep quality, and depressive symptoms have
high BC as well as CC, indicating that they may also
be important drivers of vascular and neuronal dysfunc-
tion. Furthermore, sleep deprivation and depressive
symptoms can exert direct effects that result in cogni-
tive impairment (Alhola and Polo-Kantola 2007; Rock
et al. 2014).
Fig. 1 Causal loop diagram of sporadic Alzheimer’s disease.
The diagram contains related variables and causal connections
between them. The diagram is divided into variables related to
brain health (red), physical health (yellow), and psychosocial
health (green). A positive connection (+, solid line) represents
an effect in the same direction, whereas a negative connection (-
, dotted line) represents an effect in the opposite direction. The
size of the variables is scaled by their betweenness centrality.
RD1–14 and RI1–16 represent direct and indirect reinforcing
feedback loops
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Fig. 2 The betweenness and closeness centralities of the variables in the causal loop diagram (Fig. 1). The error bars represent the
interquartile range of 1000 mutated diagrams with each 5 random rewirings, additions of deletions
Exogenous variables
Education level, head trauma, and apoE-4 carriership
are exogenous to the CLD and thus have a BC of
0. The CC of these variables, however, is relatively
high, especially of education level, suggesting that it is
an important contributor to cognitive decline (Wilson
et al. 2009). Exogenous variables influence the sys-
tem without being influenced by it. They can be seen
as part of the context of an individual and their his-
tory. They can also be seen as entry points into the
system. ApoE-4 carriership might, for example, play a
role in dyslipidemia (Marais 2019) and could thereby
contribute to AD pathogenesis.
Within and cross-scale feedback loops
Several feedback loops have been identified in the
CLD and are annotated in Fig. 1. An overview of
the feedback loops is also given in Table 1. All the
direct reinforcing loops have been denoted as RD1–
RD14. Similarly, indirect reinforcing loops, limited to
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three variables, have been denoted as RI1–RI6. None
of these loops are balancing, suggesting that balanc-
ing loops may be of less importance than reinforcing
loops for understanding cognitive decline trajectories
in sporadic AD.
Within-scale loops can significantly impact local
pathological processes and may fall within the scope
of one scientific domain. For example, at the level of
the brain, loop RD1 may aggravate neuronal dysfunc-
tion as aggregates of amyloid-beta protein may acti-
vate microglia, leading to increased release of TNF-α,
which can inhibit the phagocytosis of amyloid-beta
(Tejera and Heneka 2016).
An example of a cross-scale loop is RI1. Oxida-
tive stress can lead to an impairment of glucose
metabolism and thereby to neuronal dysfunction
Table 1 Feedback loops in the causal loop diagram (Fig. 1)
Loop 1st variable 2nd variable 3rd variable
RD1 Amyloid beta burden Neuroinflammation -
RD2 Oxidative stress Neuroinflammation -
RD3 Amyloid beta burden Cerebral endothelial dysfunction -
RD4 Brain perfusion Cerebral endothelial dysfunction -
RD5 Systemic inflammation Morbidity burden -
RD6 Motor function Physical activity -
RD7 Physical activity Depressive symptoms -
RD8 Excessive alcohol use Social relationships -
RD9 Sleep quality Experienced stress -
RD10 Depressive symptoms Experienced stress -
RD11 Depressive symptoms Cognitive functioning -
RD12 Depressive symptoms Sleep quality -
RD13 Depressive symptoms Social relationships -
RD14 Sleep quality Social relationships -
RI1 Oxidative stress Neuronal dysfunction Circadian misalignment
RI2 Physical activity Neuronal connectivity Cognitive functioning
RI3 Obesity Motor function Physical activity
RI4 Morbidity burden Motor function Physical activity
RI5 Brain perfusion Physical activity Cognitive functioning
RI6 Neuronal connectivity Cognitive functioning Engagement in cognitively demanding tasks
RI7 Morbidity burden Daily functioning Social relationships
RI8 Physical activity Sleep quality Cognitive functioning
RI9 Physical activity Depressive symptoms Social relationships
RI10 Physical activity Sleep quality Social relationships
RI11 Experienced stress Depressive symptoms Sleep quality
RI12 Experienced stress Sleep quality Depressive symptoms
RI13 Experienced stress Depressive symptoms Social relationships
RI14 Social relationships Depressive symptoms Cognitive functioning
RI15 Depressive symptoms Sleep quality Social relationships
RI16 Depressive symptoms Social relationships Sleep quality
Direct reinforcing loops (RD) consist of two variables and the indirect reinforcing loops (RI) consist of three variables
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(Butterfield and Halliwell 2019). This could lead to
circadian misalignment when it includes damage to
melanopsin-expressing retinal ganglion cells (Feng
et al. 2016) and could thereby result in exacerbated
oxidative stress (Musiek and Holtzman 2016).
Loops with more than three variables also exist and,
although they are sometimes difficult to recognize,
they may have important effects on the system (Kenzie
et al. 2018). These loops can often exist between vari-
ables at multiple spatial or temporal scales and may
be related to various scientific domains. An example
of a longer cross-scale loop is shown in Fig. 3. A dis-
turbance of sleep quality can lead to an impairment
of glymphatic system functioning (Rasmussen et al.
2018). This may aggravate amyloid-beta as well as tau
pathology (Rasmussen et al. 2018), potentially lead-
ing to neuronal dysfunction and ensuing reductions in
sleep quality (Wang and Holtzman 2020).
Example: Physical activity
Physical activity is a good example of how risk fac-
tors can exert their influence on the system through
the feedback loops they are involved in. Physical
activity is a well-established modifiable risk factor
(Livingston et al. 2017) and has high centrality in the
CLD. In Fig. 4, physical activity is highlighted in the
CLD with each connection, variable, and feedback
loop that it is connected to. Physical activity is part
of seven indirect and two direct reinforcing feedback
loops, one with motor function (RD6) and one with
depressive symptoms (RD7).
Increasing physical activity may reduce the onset
of multiple morbidities (e.g., diabetes and obesity) by
improving cardiovascular and metabolic health (Gall-
away et al. 2017) and, in turn, reduce the occurrence of
multimorbidity, all of which may prevent correspond-
ing reductions in motor function (Caldero´n-Larran˜aga
et al. 2019) and thereby result in more physical activ-
ity through RI4 as well as RD6. Increasing physi-
cal activity might also reduce depressive symptoms
by increasing brain-derived neurotrophic factor lev-
els (RD7) (Mandolesi et al. 2018). These reductions
in depressive symptoms could also lead to improved
social relationships (VanderWeele et al. 2012), which
can further stimulate physical activity (Barth et al.
2010) (RI9). Loops like RD7, which are nested in
longer loops, could induce further unexpected nonlin-
ear effects on the system.
Physical activity is also part of two cross-scale
loops that involve cognitive functioning. Increasing
physical activity may have beneficial effects on brain
perfusion (RI5) (Mandolesi et al. 2018) as well as
neuronal connectivity (RI2) via FNDC5/irisin improv-
ing synaptic plasticity (Lourenco et al. 2019), both of
which can have beneficial effects on cognitive func-
tioning (Ogoh 2017; Koen and Rugg 2019). Cross-
scale loops often include variables that are not only
separated in space but often also in time. For exam-
ple, it could take many years before a gradual loss of
Fig. 3 An example of a reinforcing cross-scale feedback loop
with four variables (from Fig. 1). The diagram is divided into
variables related to brain health (red) and psychosocial health
(green). A positive connection (+, solid line) represents an effect
in the same direction, whereas a negative connection (-, dotted
line) represents an effect in the opposite direction
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Fig. 4 Feedback loops (from Fig. 1) that include physical activ-
ity. This diagram shows the variables, causal connections, and
reinforcing direct (RD6–7) and indirect (RI2–5, RI8–10) feed-
back loops related to physical activity. The diagram is divided
into variables related to brain health (red), physical health
(yellow), and psychosocial health (green). A positive connec-
tion (+, solid line) represents an effect in the same direction,
whereas a negative connection (-, dotted line) represents an
effect in the opposite direction
neuronal connectivity results in a notable loss of cog-
nitive functioning (Koen and Rugg 2019). Loops like
RI2 could, nevertheless, significantly influence AD
onset and progression over such time scales.
Besides its bidirectional relationship with depres-
sive symptoms (R7), physical activity is also closely
related to other potentially modifiable factors with
high centrality, specifically social relationships, and
sleep quality (RI10). Figure 5 shows that depressive
symptoms are involved in many feedback loops, such
as with cognitive functioning (RD11), sleep quality
(RD12), experienced stress (RD10), and social rela-
tionships (RD13), which also have loops amongst
each other (RD9, RD14). This strong interconnection
is also apparent in several indirect loops (RI15–16,
RI11–12), in which these direct loops are nested, and
even longer overlapping loops, such as between phys-
ical activity, sleep quality, social relationships, and
depressive symptoms (Fig. 5). Such longer, cross-
scale loops, containing variables with high centrality
and having several loops nested within them, may be
crucial for understanding the onset of AD as well as
the influence of potentially modifiable risk factors.
Discussion
CLDs can be used as a system-wide map of the
multicausality of risk factors and pathophysiology of
complex biomedical issues (Wittenborn et al. 2016;
Kenzie et al. 2018). We have utilized this tool to sum-
marize expert knowledge on the multicausal etiology
of sporadic AD across scientific disciplines. The CLD
contains variables and causal relationships formulated
in a manner that this interdisciplinary group of experts
agreed on. This paves the way for intensified interdis-
ciplinary collaboration within the AD field and shows
that GMB can be utilized for eliciting, contrasting, and
integrating knowledge from AD experts across various
scientific domains.
Although its qualitative nature makes it difficult
to draw definite conclusions, the current CLD may
already have several implications. The BC and CC
point at a significant role for modifiable risk factors
in AD. High centrality makes overall effects on cog-
nitive decline via such factors more likely to occur
and also underscores that such factors are endogenous
to the disorder and bidirectionally related to under-
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Fig. 5 A cluster of long and nested feedback loops in the causal
loop diagram (Fig. 1). This diagram shows variables, causal
connections, and reinforcing feedback loops related to physi-
cal health (yellow) and psychosocial health (green). A positive
connection (+, solid line) represents an effect in the same direc-
tion, whereas a negative connection (-, dotted line) represents
an effect in the opposite direction
lying pathophysiological processes. This supports the
idea that multi-domain lifestyle interventions may be
promising, particularly when intervening on social
relationships, physical activity, diet, sleep, and depres-
sion. Their high centrality suggests that they mediate
and impact on numerous other mechanisms relevant
to AD. This is supported by results from the 2-year
Finnish Geriatric Intervention Study to Prevent Cog-
nitive Impairment and Disability (FINGER) study,
which suggests that multi-domain interventions may
maintain cognitive functioning in at-risk elderly peo-
ple (Ngandu et al. 2015). Furthermore, the relatively
high BC of cerebral endothelial dysfunction supports
the increased recognition of the role of cerebrovas-
cular dysfunction in AD and the impact of systemic
vascular health on brain health (Sweeney et al. 2019).
At the very least, the CLD emphasizes the neces-
sity of widely recognizing AD as a complex and
multicausal condition. The many relations between
the multitude of variables in the system could lead
to unexpected results when intervening in them. It
appears unlikely that a few variables or a single feed-
back loop can be isolated from the rest of the sys-
tem and fully understood independently. For instance,
potentially beneficial effects of an intervention may
be compensated by adverse effects materializing along
another pathway. It also demonstrates the need to
develop such CLDs: it is highly unlikely that an indi-
vidual domain expert has an equally encompassing
mental map as the resulting systemic CLD. The mul-
ticausality as illustrated by the CLD poses challenges
to analysis methods that are purely based on statistical
associations, such as structural equation models (Shen
et al. 2020). It reveals the need for a causal struc-
tural understanding of AD as a system of intersecting
causal pathways and loops, suggesting that there may
not even be a single, localized intervention that can
counter the disease progression by itself.
Importantly, the CLD approach to knowledge syn-
thesis we utilized here is the basis for a computational
implementation in the form of a system dynamics
model. As a next step of the empirical cycle (Hoek-
stra et al. 2019), it could be used to simulate a
variety of intervention scenarios on modifiable risk
factors over time, which may then be tested experi-
mentally. Rather than going immediately from theory
and knowledge integration to experimental validation,
simulation modeling should allow for a better under-
standing of the mechanisms underlying intervention
scenarios and could thereby help identify potential
leverage points in the system. This increased under-
standing may increase the prior probability of such
scenarios and limit the number of failed empirical
intervention studies (Ioannidis 2005, 2016). Given the
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large number of unsuccessful clinical trials (Cum-
mings et al. 2019), this may be very important indeed.
The presence of cross-scale feedback loops further
indicates a need for sustained interdisciplinary collab-
orations that consider long-range interactions between
variables typically associated with different scientific
disciplines. Many cross-scale feedback loops that can
be found in Fig. 1 are longer than three variables, such
as the loop in Fig. 5. Longer loops are not considered
in Table 1 because they are influenced by so many
variables that their interpretation becomes ambiguous
without quantitative information. Such loops could
nevertheless turn out to be critical to the behavior of
the system in a quantitative analysis.
Despite our systematic application of GMB, there
is subjectivity involved in the process. The CLD is to
some extent unique to this specific group of experts
and may not be easily replicated in a different group.
However, the ordering of the centrality measures of
the variables was robust as evidenced by the error
bars in Fig. 2, which rarely overlapped. This sug-
gests that small errors made in the wiring of the
diagram would not have resulted in different quali-
tative conclusions, especially for the variables with
high centrality. Furthermore, due to the wide range of
expertise included in our group and the embedding of
all connections in the scientific literature, such errors
are likely minimized. To assess the influence of bias
in the variable selection on the centrality measures,
we used cerebrovascular pathology as an example and
tested whether omitting white matter hyperintensities,
microbleeds, and lacunar infarcts from the CLD would
alter the BC ranking of cerebral endothelial dysfunc-
tion. This test yielded minimal changes and only
slightly lowered the BC of endothelial dysfunction to
a comparable level as cognitive functioning. Limit-
ing the level of detail was a deliberate choice by the
group and resulted in a more comprehensible CLD.
We aimed to include the most important mechanisms
that contribute to AD rather than to be completely
exhaustive. Consequently, several processes have been
combined into aggregate variables. For example, cel-
lular processes like mitochondrial dysfunction and
endoplasmic reticulum stress have been aggregated
in overarching terms such as neuronal dysfunction.
Questions at higher levels of detail can thus not yet
be addressed using the current CLD. Future efforts
could extend the CLD by increasing its level of detail,
particularly at the (sub-)cellular scale.
A pitfall of CLDs is that they exclusively contain
qualitative information. Accordingly, the centrality
measures of the variables might change considerably
when taking into account the strength of the connec-
tions. The use of centrality measures for causal impor-
tance has also been disputed recently (van Elteren
and Quax 2019; Dablander and Hinne 2019) since it
does not take into account the specific dynamics rep-
resented by the variables and connections. That being
said, high centrality variables were found to corre-
spond to known drivers of childhood obesity in a CLD
(McGlashan et al. 2016). Therefore, as a first approxi-
mation and while dynamics are not yet modeled quan-
titatively, variables with high centrality might—on the
whole—be responsible for a significant proportion of
the effect on cognitive decline in our CLD as well. At
this point, a network-structural approach for proposing
causally relevant variables is the best we can do. The
moderate-to-large monotonic correlation between BC
and CC further suggests that, although they overlap,
these measures also have complementary value. For
example, CC was useful for comparing the exogenous
variables.
The CLD remains a reflection of the knowledge of
our group of experts and of the available scientific evi-
dence. Hence, some connections that exist in reality
may have been omitted in the CLD. The implications
of this uncertainty will be assessed using uncertainty
quantification (UQ) techniques applied to the system
dynamics model. Because our CLD is the result of
GMB and our review of scientific literature was not
fully systematic, the CLD by itself does not yet pro-
vide insight into which of the connections require
further investigation. However, when computationally
implemented, the CLD could become a valuable, com-
plementary tool to systematic reviews for identifying
potentially interesting empirical research targets. In
the sequel to this work, UQ and sensitivity analy-
sis techniques applied to the system dynamics model
will be used to identify which of the connections
are important for model predictions and which would
require additional data in order to be estimated with
high confidence. Through these means, we will inves-
tigate which parts of the model require further scien-
tific research. The lack of balancing feedback loops
is likely a consequence of our aim of mapping the
mechanisms leading to cognitive decline in AD, rather
than homeostatic and resilience mechanisms. For a
fuller picture, future efforts could also aim to chart out
GeroScience
balancing loops to give a more complete representa-
tion of the system that is less skewed to factors that
promote the development and progression of clinically
manifest AD and instead also includes factors that
counteract mechanisms of disease progression.
Although the CLD is, just like any other model
(Sterman 2002), an incomplete representation of real-
ity, it can still be used for educational purposes,
hypothesis generation, and the identification of con-
founder and collider variables to consider in statistical
analyses (VanderWeele 2019). Furthermore, the CLD
is the first step in an iterative process of not only devel-
oping computational models but also further mapping
out the processes implicated in AD. As such, it could
become increasingly exhaustive, reaching levels of
detail like the Foresight system map developed for
obesity (Vandenbroeck et al. 2007).
We have the ambition of turning this work into
an ongoing effort of the scientific community to
expand and parameterize the model we developed,
but a rigorous methodology for such a community-
level approach must still be developed. For now, we
encourage AD researchers to use our online version
of the CLD to make suggestions for improvements
or extensions using the designated comment function.
Additional systematic methods for triangulation and
extending the CLD might entail word cloud analyses
(Atenstaedt 2012) in order to identify important vari-
ables that are not currently present in the diagram, or
systemic reviews which could be conducted for every
connection that might plausibly exist between any of
the variables in the CLD. In addition, quality assess-
ment criteria could be developed for the application
of GMB to complex scientific issues, similar to the
PRISMA criteria for systematic reviews (Moher et al.
2009). This would promote the quality and wide-scale
reliable application of GMB and of mixed quantitative
and qualitative methods.
Conclusion
This work demonstrates the relevance and feasibility
of using systems thinking and GMB to improve our
understanding of the biopsychosocial causality in AD.
Our study specifically serves as a proof-of-concept
of this innovative method in the AD field. The gen-
eral notion that AD is complex and multicausal is
supported by the large number of variables, causal
connections, and feedback loops that we have iden-
tified in the system, which exist at multiple spatial
and time scales. As such, this work is complemen-
tary to scientific approaches confined to a single
mechanism that cannot fully account for the inter-
active behavior of the network of multiple causes at
different scales.
We will use the CLD for the development of a
system dynamics model. This model will be cali-
brated and validated using empirical data of longi-
tudinal cohort studies and randomized clinical trials.
By these means, it may become an important tool for
simulating and predicting cognitive and global func-
tional performance effects of multi-domain lifestyle or
drug interventions. We believe that GMB and systems
thinking should be further developed for and applied
to complex multicausal conditions, particularly AD.
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